Toxocariasis of the Nervous System.


Journal

Acta parasitologica
ISSN: 1896-1851
Titre abrégé: Acta Parasitol
Pays: Switzerland
ID NLM: 9301947

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 13 10 2019
accepted: 30 12 2019
pubmed: 22 1 2020
medline: 4 3 2021
entrez: 22 1 2020
Statut: ppublish

Résumé

Toxocariasis is a helminthozoonosis caused by the infection of a human host by the larva of Toxocara spp., predominately involving Toxocara canis and Toxocara cati, which are common nematodes in dogs and cats, respectively. Human transmission occurs through contact with animals or by consumption of food contaminated with parasite's eggs. The purpose of this article is to review the current knowledge regarding human neurotoxocariasis. We conducted a systematic review of the existing literature concerning toxocariasis of the nervous system. Clinical spectrum of human toxocariasis varies widely from a subclinical course to significant organ morbidity. Clinical course depends on parasitic load, the migration route of the larvae and host response. Human neurotoxocariasis is a relatively rare entity yet associated with severe sequelae. Manifestations include meningitis (usually eosinophilic), encephalitis, myelitis, cerebellar vasculitis, space-occupying lesion, behavioral abnormalities, and optic neuritis. Even though valid diagnostic criteria are lacking, neurotoxocariasis should be suspected in patients with neurologic symptoms and cerebrospinal fluid (CSF) pleocytosis with eosinophilia, positive serology for anti-Toxocara antibodies, in serum and/or CSF, sterile CSF and clinical improvement after antihelminthic treatment. Neurotoxocariasis is treated by benzimidazole components, most frequently albendazole, corticosteroids, or diethylcarbamazine. Parasite larvae migrate through tissues and are able to reach the nervous system causing neurotoxocariasis. Its clinical spectrum varies and includes myelitis, meningoencephalitis, brain abscess, and vasculitis. Neurotoxocariasis should always be suspected in patients with neurologic symptoms accompanied by eosinophilia in blood and/or CSF. Early diagnosis and treatment could prevent long-term neurologic impairment.

Identifiants

pubmed: 31960218
doi: 10.2478/s11686-019-00166-1
pii: 10.2478/s11686-019-00166-1
doi:

Substances chimiques

Anthelmintics 0
Nitroimidazoles 0
benzonidazole YC42NRJ1ZD

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

291-299

Auteurs

Maria Meliou (M)

Infectious Diseases Unit, 3rd Department of Internal Medicine, Red Cross Hospital, Athens, Greece.
"C.N.S. Alliance" Research Group, Athens, Greece.

Ioannis N Mavridis (IN)

"C.N.S. Alliance" Research Group, Athens, Greece. pap-van@otenet.gr.

Efstratios-Stylianos Pyrgelis (ES)

"C.N.S. Alliance" Research Group, Athens, Greece.
1st Department of Neurology, Medical School, "Eginition" Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Eleni Agapiou (E)

"C.N.S. Alliance" Research Group, Athens, Greece.
Department of Physical Medicine and Rehabilitation, "Asklepieion" General Hospital, Voula, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH